Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Exchange
OTC Link
ADRC
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $47.4M | $2.1M | $841.0K | $1.4M | $11.4M | $2.0M | $9.3M | $1.4M |
| Cost of revenue | $2.2M | $1.7M | $1.5M | $1.3M | $1.8M | $695.2K | $1.1M | $0 |
| Gross profit | $45.2M | $437.0K | −$616.0K | $180.0K | $9.6M | $1.3M | $8.2M | $0 |
| Gross margin | 95.4% | 20.4% | -73.2% | 12.5% | 83.9% | 64.4% | 88.0% | 0.0% |
| R&D | $25.8M | $23.3M | $22.5M | $20.0M | $25.9M | $0 | $0 | $13.6M |
| Operating income | $9.7M | −$22.0M | −$21.1M | −$19.4M | −$18.4M | −$12.9M | −$7.4M | −$17.4M |
| EBITDA | $13.0M | −$20.0M | −$20.0M | −$19.3M | −$3.6M | −$17.6M | −$6.9M | −$17.4M |
| Net income | $7.6M | −$18.6M | −$23.3M | −$22.8M | −$6.9M | −$19.2M | −$9.3M | −$15.9M |
| Net margin | 16.1% | -868.1% | -2773.4% | -1575.8% | -60.3% | -984.3% | -100.0% | -1124.8% |
| EPS (diluted) | 1.00 | -2.68 | -3.34 | -3.22 | -0.86 | -1.74 | -0.66 | -0.81 |
Annual figures · source: Financial Modeling Prep
| Year | Est. revenue | Est. EPS | EPS range | # Analysts |
|---|---|---|---|---|
| 2026 | $45M | $0.18 | $0.18–$0.18 | 1 |
| 2027 | $11M | $-0.60 | $-0.60–$-0.60 | 1 |
| 2028 | $16M | $-0.30 | $-0.30–$-0.30 | 1 |
| 2029 | $29M | $0.59 | $0.59–$0.59 | 1 |
Forward consensus · source: Financial Modeling Prep
ADOCIA S/ADR
No one on the platform currently holds ADOCY.
No tracked institution reports a position in ADOCY as of their last filing.
No one on the platform has traded ADOCY yet.
| $42M |
| — |
| EKDHFEKF Diagnostics Holdings plc | $0.35 | +0.00% | $149M | — |
| EPRXFEupraxia Pharmaceuticals Inc. | $3.04 | -6.17% | $108M | — |
Source: Financial Modeling Prep · peers by sector/industry
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.